AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

GSA CAPITAL PARTNERS LLP's Holding History (CIK: 0001362033)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 36,758 Value ($000) $0 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 52,107 Value ($000) $1 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 170,533 Value ($000) $1 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 23,085 Value ($000) $0 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 10,639 Value ($000) $0 Avg Close $4.71 Range $2.91 - $7.27
Q1 2024
Shares 79,652 Value ($000) $0 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 132,177 Value ($000) $2 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 42,435 Value ($000) $1 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 14,004 Value ($000) $0 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 8,109 Value ($000) $0 Avg Close $34.74 Range $26.64 - $41.93